Sustained Therapies Ltd

The World Health Organization (WHO) recently released its updated Priority Bacterial Pathogens List for 2024, emphasizing the critical need to address the growing threat of antimicrobial resistance (AMR). At Sustained Therapies, we recognize the severity of this issue and are committed to developing innovative, end-to-end solutions to tackle AMR head-on.

News Alert! After years in the making, the European Pharmacopoeia Commission has adopted a new general chapter on ‘phage therapy medicinal products’, providing a framework of requirements for their production and control in an effort to standardize requirements for phage therapy.   https://lnkd.in/ehbnd2Pf  

Explore Forbes' latest article by Rob Kniaz to uncover the transformative potential of #phages in combating antibiotic resistance. Read more for an insightful glimpse into the future #bacteriophage https://lnkd.in/dEk9NDnv

Today, on International Women's Day, let's meet the amazing women within our group.

Get the most out of bacteriophages with these 3 tips for working with them. #bacteriophages #phagetherapy #SustaniedTherapies

We are happy to introduce Mordechai Tor, our new Process Engineer at Sustained Therapies. Mordechai brings knowledge and experience in Bio-process Engineering, along with a deep passion for developing innovative bioprocessing solutions. Holding a B.Sc, in Biotechnology Engineering, Mordechai's is just what we were looking for. A dedicated, motivated process engineer who at the same time is a great guy to work with. #sustaniedtherapies #newteammember #phagetherapy

We wish you a prosperous, peaceful, and breakthrough year in 2024. #sustainedtherapies #nomatterwhat

The Revival of Phage Therapy☀️ #phagetherapy

Wishing everyone a Merry Christmas, a prosperous and peaceful New Year! Let's cherish these moments with family and friends and recharge for the year ahead.

🌌 Fascinating Discovery in Space Microbiology: Bacteriophage-Host Dynamics in Microgravity! 🚀 We're excited to share a groundbreaking study conducted onboard the International Space Station (ISS), shedding light on a rarely explored aspect of microbiology - the impact of microgravity on bacteriophage-host interactions. 🔬 Study Overview: Researchers investigated the interactions between T7 bacteriophage and E. coli in the unique environment of microgravity. Findings revealed that phage activity, while initially delayed in microgravity, was ultimately successful. The study identified novel mutations in both the phage and E. coli, suggesting adaptation to the microgravity conditions. 🌟 Why This Matters: This research provides invaluable insights into microbial and viral behaviors in space, which is crucial for future, long-term space missions and astronaut health. It also opens new avenues for understanding microbial dynamics in unique environments.   🧬 Key Takeaways: The study emphasizes the resilience and adaptability of microorganisms and viruses in extreme conditions. These findings could have significant implications for biotechnology and health science, both in space and on Earth. 📖 Read the Full Study: https://lnkd.in/eDM32dZQ #phagetherapy #nomatterwhat